4//SEC Filing
CTI BIOPHARMA CORP 4
Accession 0000891293-15-000071
CIK 0000891293operating
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 6:53 PM ET
Size
8.2 KB
Accession
0000891293-15-000071
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-12-23+1,100,000→ 1,100,000 totalExercise: $1.24Exp: 2015-12-23→ Common Stock (1,100,000 underlying) - Disposition to Issuer
Performance Rights
2015-12-23−406,483→ 0 totalExercise: $0.00→ Common Stock (406,483 underlying)
Footnotes (2)
- [F1]In a Form 4 filed on July 29, 2015, the reporting person reported the acquisition of the number of performance rights identified in the table above that related to the issuer's achievement of a market capitalization goal. That award no longer represents the right to receive shares of the issuer's common stock. Instead, if the applicable performance goal is achieved by December 31, 2016, the reporting person will be entitled to the grant of a stock option with respect to the same number of shares that would have been issued to the reporting person upon achievement of the goal under the original terms of the award.
- [F2]The option is scheduled to vest in eight semi-annual installments over the four-year period following the grant date, subject to the reporting person's continued employment or service with the issuer through the applicable vesting date.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000891293
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 6:53 PM ET
- Size
- 8.2 KB